Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Administrators return Blue Horseshoe back to Directors as Aspermont pores over its 44% stake

  • In News
  • November 22, 2023
  • Alinda Gupta
Administrators return Blue Horseshoe back to Directors as Aspermont pores over its 44% stake

In August 2021, media services company Aspermont (ASX: ASP) co-founded a FinTech startup, Blue Horseshoe Ventures, that was set to democratise and revolutionise the investment space. The same digital capital-raising platform has since entered voluntary administration and been returned to its directors.

On August 17, 2023, the Company said Blue Horseshoe Ventures had entered voluntary administration. Aspermont had an exposure of $670k in working capital loans at the time and agreed to fund a maximum of $100k for the voluntary administration process. 

Since then, Aspermont has undertaken initiatives to recover the funds. And with Blue Horseshoe having been handed over to its directors, it might have some luck on that front.

Blue Horseshoe is a FinTech business that Aspermont has helped launch with partners—Spark Plu and International Pacific Capital (IPC). It is a capital-raising platform for the ASX market enabling a wider range of investors to access private placements and IPOs in that market.

Aspermont is the largest shareholder with a 44% stake, and at the end of 2022, it had increased its shareholding by $400k. While building the startup, Aspermont saw an opportunity to leverage its existing corporate and investor audiences for the new venture whilst, at the same time, enhancing its own offerings through the provision of additional complimentary services that will come from it.

However, it appears that the idea didn’t age well. 

In May 2023, when the Company suffered a $900k loss, up from PCP’s $200k, it noted that its investment in Blue Horseshoe was part of the reason. 

Kimberley Stuart Wallman and Gregory Paul Quin, registered liquidators, chartered accountants and partners of HLB Mann Judd Insolvency WA, were appointed as joint and several administrators of Blue Horseshoe. After a creditor’s meeting on November 21, 2023, creditors agreed to a Deed of Company Arrangement, where business control will return to the directors of BHV. 

Aspermont is not expecting the ordeal to have a major impact on its operations as it has been seeing revenue growth across its other ventures. In October 2023, the Company announced the successful launch of its two co-located events, the Future of Mining (FOM) and MiningNews Select (MJS) in Perth on September 18 and 19, Aspermont’s biggest event to date. These events—covering the mining landscape—brought in $1.2 million in revenue. 

In the third quarter of 2023, Aspermont’s total revenue saw a 4% YoY increase to $4.4 million. Its subscription revenue was $2.3 million, with the content works revenue seeing a 170% uplift to $200k. 

In this period, it launched SCOUT for customer data analytics, the Perth events, and the Mining News Select, which sold out 12 weeks prior to launch. Aspermont’s focus is on market growth and expansions. However, since its exposure to Blue Horseshoe is rather big, shareholders await the FY24 report to see how it influences the Company’s overall financials. 

More details on BHV and Aspermont’s role are set to come out in the next seven to 14 days.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • aspermont
  • asx asp
  • Blue Horseshoe Ventures
  • Fintech
  • Gregory Paul Quin
  • Kimberley Stuart Wallman
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.